Identification of strain harboring both aac(6')-Ib and aac(6')-Ib-cr variant simultaneously in Escherichia coli and Klebsiella pneumoniae
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The aac(6')-Ib gene is the most prevalent gene that encodes aminoglycoside-modifying enzymes and confers resistance to tobramycin, kanamycin, and amikacin. The aac(6')-Ib-cr variant gene can induce resistance against aminoglycoside and fluoroquinolone simultaneously. Two main methods, sequence analysis and the restriction enzyme method, can detect the aac(6')-Ib-cr variant in clinical strains. We collected the 85strains that were believed to be aac(6')-Ib positive from clinical isolates. Among them, 38 strains were the wild-type; the remaining 47 strains were the aac(6')-Ib-cr variant. Of these 47strains, 19 simultaneously harbored aac(6')-Ib and aac(6')-Ibcr. Our study aims to report the characteristics of the 19 strains that simultaneously harbored both genes. This study is the first investigation published in Korea of strains that included both aac(6')-Ib and aac(6')-Ib-cr variant. [BMB reports 2011; 44(4):262-266]
Abstract
The aac(6')-Ib gene is the most prevalent gene that encodes aminoglycoside-modifying enzymes and confers resistance to tobramycin, kanamycin, and amikacin. The aac(6')-Ib-cr variant gene can induce resistance against aminoglycoside and fluoroquinolone simultaneously. Two main methods, sequence analysis and the restriction enzyme method, can detect the aac(6')-Ib-cr variant in clinical strains. We collected the 85strains that were believed to be aac(6')-Ib positive from clinical isolates. Among them, 38 strains were the wild-type; the remaining 47 strains were the aac(6')-Ib-cr variant. Of these 47strains, 19 simultaneously harbored aac(6')-Ib and aac(6')-Ibcr. Our study aims to report the characteristics of the 19 strains that simultaneously harbored both genes. This study is the first investigation published in Korea of strains that included both aac(6')-Ib and aac(6')-Ib-cr variant. [BMB reports 2011; 44(4):262-266]
참고문헌 (21)
- Hooper, D. C, "Mechanisms of action and resistance of older and newer fluoroquinolones", Clin. Infect. Dis, 31, pp.S24~S28 (2000)
- Robicsek, A, "The worldwide emergence of plasmid-mediated quinolone resistance", Lancet Infect. Dis, 6, pp.629~640 (2006)
- Vakulenko, S. B, "Versatility of aminoglycosides and prospects for their future", Clin. Microbiol. Rev, 16, pp.430~450 (2003)
- Tolmasky, M. E, "Molecular cloning of amikacin resistance determinants from a Klebsiella pneumoniae plasmid", Antimicrob. Agents Chemother, 30, pp.315~320 (1986)
- Robicsek, A, "Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase", Nat. Med, 12, pp.83~88 (2006)
- Hidalgo-Grass, C, "High-resolution melt curve analysis for identification of single nucleotide mutations in the quinolone resistance gene aac(6')-Ib-cr", Antimicrob. Agents Chemother, 54, pp.3509~3511 (2010)
- Martínez-M., L, "Plasmid-mediated quinolone resistance", Expert. Rev. Anti-Infect. Ther, 6, pp.685~711 (2008)
- Strahilevitz, J, "Plasmid-Mediated quinolone resistance: a multifaceted threat", Clin. Microbiol. Rev, 22, pp.664~689 (2009)
- Flórez, A. B, "Acquired macrolide resistance in the human intestinal strain Lactobacillus rhamnosus E41 associated with a transition mutation in 23S rRNA genes", Int. J. Antimicrob. Agents, 30, pp.341~344 (2007)
- Turnpenny, P. D, "Emery's Elements of Medical Genetics. 13th ed." (2007), Elsevier Limited
- Guillard, T, "Rapid detection of quinolone resistance gene aac(6')-Ib-cr by pyrosequencing", J. Clin. Microbiol, 48, pp.286~289 (2009)
- Bell, J. M, "aac(6')- Ib-cr genotyping by simultaneous high resolution melting analysis of an unlabelled probe and full length amplicon.", Antimicrob. Agents Chemother, 54, pp.1378~1380 (2010)
- Park, C. H, "Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin modifying enzyme", Antimicrob. Agents Chemother, 50, pp.3953~3955 (2006)
- Robicsek, A, "qnr prevalence in ceftazidime- resistant Enterobacteriaceae isolates from the United States", Antimicrob. Agents Chemother, 50, pp.2872~2874 (2006)
- Robicsek, A, "Fluoroquinolone modifying enzyme: a novel adaptation of a common aminoglycoside acetyltransferase", Nat. Med, 12, pp.83~88 (2006)
- Katsumi, S, "Rapid detection of gyrA and parC mutations in fluoroquinoloneresistant Neisseria gonorrhoeae by denaturing high-performance liquid chromatography", J. Microbiol. Met, 59, pp.415~421 (2004)
- Deborah, J. E, "Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography", J. Clin. Microbiol, 40, pp.4121~4125 (2002)
- Heisig, P, "Mutations in the gyrA gene of a highly fluoroquinolone- resistant clinical isolate of Escherichia coli", Antimicrob. Agents Chemother, 37, pp.696~701 (1993)
- Vila, J, "Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs", Antimicrob. Agents Chemother, 38, pp.2477~2479 (1994)
- Kim, H. B, "oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae", Antimicrob. Agents Chemother, 53, pp.3582~3584 (2009)
- Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement, "Clinical and Laboratory Standards Instit", Wayne, ~, pp.M2-A9 and M7-A7 (2008)